Epidermal growth factor receptor and variant III targeted immunotherapy

Immunotherapeutic approaches to cancer have shown remarkable promise. A critical barrier to successfully executing such immune-mediated interventions is the selection of safe yet immunogenic targets. As patient deaths have occurred when tumor-associated antigens shared by normal tissue have been tar...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Congdon, Kendra L., Gedeon, Patrick C., Suryadevara, Carter M., Caruso, Hillary G., Cooper, Laurence J.N., Heimberger, Amy B., Sampson, John H.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2014
Θέματα:
Invited Reviews
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4207138/
https://ncbi.nlm.nih.gov/pubmed/25342601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou236
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια